Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 12, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

May 31, 2024

Conditions
Coronary Artery DiseaseDrug Coated-balloonIntravascular UltrasoundPlaque ModificationPercutaneous Coronary InterventionMicrovascular Coronary Artery Disease
Interventions
DEVICE

Drug coated-balloon percutaneous coronary intervention.

Patients will undergo DCB-PCI under IVUS guidance (OpticrossTMHD 60 MHz). Target lesion will be predilated with semi-compliant balloons or non-compliant balloons.The lesion will be then treated with DCB with a reference vessel diameter/balloon diameter ratio of 1.

DEVICE

Angiography-derived coronary physiology (IMRangio)

Angiography-derived coronary physiology will be assessed after the procedure using Angio Plus software (Pulse Medical Imaging Technology, Shanghai, China). The angiography images will be used to obtain the IMRangio values, prior and post to DCB-PCI

Trial Locations (1)

46026

RECRUITING

Hospital Universitario y Politécnico La Fe, Valencia

All Listed Sponsors
lead

Hospital Universitario La Fe

OTHER